Citation Formats
IPS-3 Validation in 1012 cases with classical hodgkin lymphoma
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

S. PAYDAŞ Et Al. , "IPS-3 Validation in 1012 cases with classical hodgkin lymphoma," LEUKEMIA RESEARCH , vol.102, 2021

PAYDAŞ, S. Et Al. 2021. IPS-3 Validation in 1012 cases with classical hodgkin lymphoma. LEUKEMIA RESEARCH , vol.102 .

PAYDAŞ, S., Lacin, S., Dogan, M., BARIŞTA, İ., Yildiz, B., SEYDAOĞLU, G., ... Karadurmus, N.(2021). IPS-3 Validation in 1012 cases with classical hodgkin lymphoma. LEUKEMIA RESEARCH , vol.102.

PAYDAŞ, SEMRA Et Al. "IPS-3 Validation in 1012 cases with classical hodgkin lymphoma," LEUKEMIA RESEARCH , vol.102, 2021

PAYDAŞ, SEMRA Et Al. "IPS-3 Validation in 1012 cases with classical hodgkin lymphoma." LEUKEMIA RESEARCH , vol.102, 2021

PAYDAŞ, S. Et Al. (2021) . "IPS-3 Validation in 1012 cases with classical hodgkin lymphoma." LEUKEMIA RESEARCH , vol.102.

@article{article, author={SEMRA PAYDAŞ Et Al. }, title={IPS-3 Validation in 1012 cases with classical hodgkin lymphoma}, journal={LEUKEMIA RESEARCH}, year=2021}